EA201491618A1 - Рекомбинантные антитела с двойной специфичностью к ганглиозидам и их применение - Google Patents

Рекомбинантные антитела с двойной специфичностью к ганглиозидам и их применение

Info

Publication number
EA201491618A1
EA201491618A1 EA201491618A EA201491618A EA201491618A1 EA 201491618 A1 EA201491618 A1 EA 201491618A1 EA 201491618 A EA201491618 A EA 201491618A EA 201491618 A EA201491618 A EA 201491618A EA 201491618 A1 EA201491618 A1 EA 201491618A1
Authority
EA
Eurasian Patent Office
Prior art keywords
antibodies
gangliosides
application
recombinant antibodies
double specificity
Prior art date
Application number
EA201491618A
Other languages
English (en)
Russian (ru)
Inventor
Эрнесто Морено Фриас
Гертрудис РОХАС ДОРАНТЕС
Ана Виктория Касадесус Пасос
Original Assignee
Сентро Де Инмунологиа Молекулар
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=48039960&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=EA201491618(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Сентро Де Инмунологиа Молекулар filed Critical Сентро Де Инмунологиа Молекулар
Publication of EA201491618A1 publication Critical patent/EA201491618A1/ru

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/30—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants from tumour cells
    • C07K16/3076—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants from tumour cells against structure-related tumour-associated moieties
    • C07K16/3084—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants from tumour cells against structure-related tumour-associated moieties against tumour-associated gangliosides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/30—Immunoglobulins specific features characterized by aspects of specificity or valency
    • C07K2317/33—Crossreactivity, e.g. for species or epitope, or lack of said crossreactivity
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/50—Immunoglobulins specific features characterized by immunoglobulin fragments
    • C07K2317/56—Immunoglobulins specific features characterized by immunoglobulin fragments variable (Fv) region, i.e. VH and/or VL
    • C07K2317/565—Complementarity determining region [CDR]

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Cell Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Apparatus Associated With Microorganisms And Enzymes (AREA)
EA201491618A 2012-03-01 2013-02-21 Рекомбинантные антитела с двойной специфичностью к ганглиозидам и их применение EA201491618A1 (ru)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CU20120035A CU24120B1 (es) 2012-03-01 2012-03-01 Anticuerpos recombinantes con especificidad dual por los gangliósidos n-acetil gm3 y n-glicolil gm3
PCT/CU2013/000001 WO2013127373A2 (es) 2012-03-01 2013-02-21 Anticuerpos recombinantes con especificidad dual por gangliósidos y su uso

Publications (1)

Publication Number Publication Date
EA201491618A1 true EA201491618A1 (ru) 2014-12-30

Family

ID=48039960

Family Applications (1)

Application Number Title Priority Date Filing Date
EA201491618A EA201491618A1 (ru) 2012-03-01 2013-02-21 Рекомбинантные антитела с двойной специфичностью к ганглиозидам и их применение

Country Status (22)

Country Link
US (1) US9527920B2 (zh)
EP (1) EP2821417A2 (zh)
JP (1) JP5933044B2 (zh)
KR (1) KR20140126349A (zh)
CN (1) CN104136463B (zh)
AR (1) AR090207A1 (zh)
AU (1) AU2013225453A1 (zh)
CA (1) CA2865050A1 (zh)
CL (1) CL2014002236A1 (zh)
CO (1) CO7051011A2 (zh)
CU (1) CU24120B1 (zh)
EA (1) EA201491618A1 (zh)
HK (1) HK1198654A1 (zh)
IL (1) IL234394A0 (zh)
MX (1) MX2014010456A (zh)
PE (1) PE20142277A1 (zh)
PH (1) PH12014501950A1 (zh)
SG (1) SG11201405151YA (zh)
TN (1) TN2014000330A1 (zh)
TW (1) TW201348259A (zh)
WO (1) WO2013127373A2 (zh)
ZA (1) ZA201407043B (zh)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CU24120B1 (es) * 2012-03-01 2015-08-27 Ct De Inmunología Molecular Anticuerpos recombinantes con especificidad dual por los gangliósidos n-acetil gm3 y n-glicolil gm3
CN104651314B (zh) * 2015-02-14 2018-06-19 百泰生物药业有限公司 获得高产稳定表达细胞克隆的方法及由此获得的抗体分子
CN107438620A (zh) * 2015-03-31 2017-12-05 韦斯夸尔德有限公司 多肽

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4107154A1 (de) 1990-10-11 1992-04-16 Boehringer Mannheim Gmbh Monoklonale antikoerper gegen melanom
CU22731A1 (es) 1998-02-05 2002-02-28 Centro Inmunologia Molecular Anticuerpo monoclonal que reconoce el oligosacárido ácido siálico n´glicolilado-galactosa-glucosa (ngcneu-gal-glu) en tumores malignos y composiciones farmacéuticas que los contienen
CU23403A1 (es) * 2003-04-23 2009-08-04 Centro Inmunologia Molecular Anticuerpos recombinantes y fragmentos que reconocen el gangliósido n-glicolil gm3 y su uso para diagnóstico y tratamiento de tumores
CU24120B1 (es) * 2012-03-01 2015-08-27 Ct De Inmunología Molecular Anticuerpos recombinantes con especificidad dual por los gangliósidos n-acetil gm3 y n-glicolil gm3

Also Published As

Publication number Publication date
KR20140126349A (ko) 2014-10-30
JP5933044B2 (ja) 2016-06-08
JP2015516367A (ja) 2015-06-11
HK1198654A1 (zh) 2015-05-22
TN2014000330A1 (en) 2015-12-21
CU24120B1 (es) 2015-08-27
WO2013127373A3 (es) 2013-10-31
MX2014010456A (es) 2014-10-13
CN104136463B (zh) 2016-08-24
EP2821417A9 (en) 2015-04-01
US20150093385A1 (en) 2015-04-02
CA2865050A1 (en) 2013-09-06
CN104136463A (zh) 2014-11-05
US9527920B2 (en) 2016-12-27
EP2821417A2 (en) 2015-01-07
TW201348259A (zh) 2013-12-01
PH12014501950A1 (en) 2014-11-24
AU2013225453A1 (en) 2014-09-25
IL234394A0 (en) 2014-10-30
PE20142277A1 (es) 2015-01-15
CO7051011A2 (es) 2014-09-10
ZA201407043B (en) 2015-12-23
WO2013127373A2 (es) 2013-09-06
SG11201405151YA (en) 2014-10-30
CU20120035A7 (es) 2013-10-29
CL2014002236A1 (es) 2014-12-05
AR090207A1 (es) 2014-10-29

Similar Documents

Publication Publication Date Title
PH12016500943A1 (en) Aplnr modulatros and uses thereof
EA201492101A1 (ru) Антитела против fcrn
MX2015012122A (es) Conjugados de anticuerpo-farmaco y los anticuerpos correspondientes.
TN2015000396A1 (en) Antibody drug conjugates
MX2016002571A (es) Regulador de ph de transduccion.
MX369148B (es) Agentes de unión kir3dl2.
PH12015500480A1 (en) Antibody formulations and uses thereof
UA115540C2 (uk) Антитіло до il-36r
EA201591072A1 (ru) Антитела против pdgfr-бета и их применения
MX2013004897A (es) Anticuerpos y composiciones anti-her3.
UA115439C2 (uk) Гуманізоване антитіло, яке розпізнає альфа-синуклеїн
EA201591806A1 (ru) Лечение и профилактика острой почечной недостаточности с применением анти-альфа-v-бета-5 антител
PH12017500864A1 (en) Anti-notch1 antibodies
EA201291039A1 (ru) Антитела, связывающие cd27 человека, и их применение
MX360368B (es) Regiones de anticuerpo modificado y sus usos.
EA201401065A1 (ru) Ang2-связывающие молекулы
EA201591791A1 (ru) Антитела pac1 человека
BR112016002401A2 (pt) métodos para reduzir as taxas de exacerbação de asma usando benralizumab
EA201291065A1 (ru) Антитела против vla-4
EA201690992A1 (ru) Антитела, специфичные к fcrn
PH12015501360A1 (en) Bmp-6 antibodies
MX2015008117A (es) Anticuerpos anti-h7cr.
TR201910413T4 (tr) Benralizumab kullanarak astım semptomlarının iyileştirilmesine yönelik yöntemler.
EA201491618A1 (ru) Рекомбинантные антитела с двойной специфичностью к ганглиозидам и их применение
TH158323A (th) รีคอมบิแนนท์แอนติบอดีที่มีสองความจำเพาะสำหรับแกงกลิโอไซด์ และการใช้ของพวกมัน